SABS लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 20:05):
Our systems believe the stock currently is overvalued by -0.28% compare to its pairs and should correct downwards.

Stats
आज की मात्रा	887
औसत मात्रा	15 945
बाजार मूल्य	26.67M
EPS	$-0.540 ( Q1 \| 2024-05-20 )
अगली कमाई की तारीख	( $-1.130 ) 2024-08-19
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.430 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0880 (3.04%)

AADI -2.65%

ABCL 1.79%

ABCM 0.04%

ABEO -2.38%

ABIO -1.68%

ABOS 1.64%

ABSI 2.72%

ABUS -2.24%

ABVX -3.53%

ACAD -0.71%

ACER -17.95%

ACET -4.73%

ACGN 1.29%

ACHL -4.15%

ACHV -1.83%

ACIU -0.50%

ACLX -0.13%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.79%

ADGI 0.87%

ADIL 0.54%

ADMA -2.50%

ADPT -0.15%

ADTX -3.47%

ADVM -3.18%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.88%

AGIO -1.88%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.48%

AKRO -2.77%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.11%

ALEC -3.90%

ALGS -2.41%

ALKS -0.21%

ALLK -8.90%

ALLO -6.45%

ALLR -4.09%

ALNA 3.16%

ALNY 1.69%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -9.24%

ALVR 0.93%

ALXN 0.00%

ALXO -10.43%

ALZN 4.78%

AMRN 0.26%

AMTI -3.13%

ANAB 0.80%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.22%

ANPC -3.15%

APGE -0.99%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.02%

APLT -4.28%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 4.70%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -3.89%

ARDS -14.23%

ARDX -0.91%

ARGX -0.80%

ARNA 0.00%

ARPO -0.90%

ARQT -0.47%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.21%

ARWR -1.88%

ASLN -3.44%

ASMB -5.19%

ASND -0.91%

ATAI -1.46%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.99%

ATOS 3.39%

ATRA -2.89%

ATXI 1.93%

ATXS -1.22%

AUPH -0.99%

AURA -0.15%

AUTL -1.87%

AVBP -2.86%

AVEO 0.00%

AVIR -0.15%

AVRO -1.41%

AVTE -4.86%

AVTX -1.25%

AVXL -2.59%

AXLA 0.00%

AXSM -1.73%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.73%

BCAB 3.59%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.60%

BCRX 1.40%

BCTX 8.12%

BCTXW -22.14%

BCYC 0.55%

BDRX -5.18%

BDTX -0.85%

BEAM 0.08%

BFRA -2.91%

BGNE -2.19%

BIOR -3.40%

BIVI 0.56%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.54%

BMEA -9.47%

BMRN 0.39%

BNOX -2.22%

BNTC -2.11%

BNTX -1.21%

BOLD -7.90%

BOLT -0.18%

BPMC -1.15%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 23.66%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.33%

CABA 0.35%

CADL -0.98%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -2.80%

CARA -0.62%

CARM 12.13%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.94%

CCCC -5.42%

CCXI 0.00%

CDAK 0.00%

CDIO -2.02%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC -0.41%

CDXS 4.31%

CELC -3.82%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.81%

CERO -3.60%

CEROW -10.18%

CFRX -27.95%

CGEM -2.74%

CGEN -3.31%

CGON -0.32%

CGTX -4.55%

CHMA -6.00%

CHRS -0.32%

CINC 0.00%

CING 0.68%

CINGW 34.95%

CKPT -2.88%

CLBS -16.75%

CLDX -2.32%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.24%

CLSD -2.90%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -8.03%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -40.07%

CNST 0.00%

CNTA -0.51%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -3.00%

CORT 2.14%

COYA -1.46%

CPRX -0.86%

CRBP -1.85%

CRBU -4.83%

CRDF -2.21%

CRGX 1.28%

CRIS -0.38%

CRNX -5.95%

CRSP 1.07%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -3.31%

CTNM -2.13%

CTXR 1.03%

CUE 3.63%

CVAC -1.98%

CVKD 0.15%

CWBR 2.80%

CYAD -12.96%

CYCC 9.84%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.04%

CYTO -2.73%

DARE 6.54%

DAWN 0.30%

DBTX -0.81%

DBVT -2.08%

DFFN 10.28%

DICE 0.06%

DMAC 33.93%

DNLI -1.92%

DNTH -6.31%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.51%

DTIL 1.36%

DYAI 9.68%

EARS -1.77%

EDIT -2.52%

EDSA -1.00%

EFTR 7.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -4.56%

ELOX 7.69%

ELTX -0.88%

ELVN -4.52%

ELYM 0.77%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.11%

ENTA -0.49%

ENTO -0.07%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON -0.30%

ETTX 0.00%

EVAX -2.14%

EVGN 6.35%

EVLO 0.00%

EWTX 0.03%

EXAI -0.95%

EXEL -0.25%

EYEG -0.69%

EYEN 1.51%

EYPT -0.12%

FATE -7.93%

FBIO 0.59%

FBIOP 0.92%

FBLG -16.60%

FBRX -0.04%

FDMT -4.77%

FENC -1.29%

FGEN -4.70%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.48%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.36%

FULC -3.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.31%

GANX -1.42%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.76%

GHRS -1.94%

GLMD -2.15%

GLPG -2.26%

GLSI 2.80%

GLTO -0.57%

GLUE -1.58%

GLYC -10.03%

GMAB -0.47%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 0.88%

GNPX 0.98%

GNTA 3.94%

GOSS -7.82%

GOVX 5.22%

GOVXW -49.04%

GPCR -6.98%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.00%

GRTX 0.00%

GTHX 0.68%

GUTS -5.31%

GXGXW 41.67%

GYRE -7.08%

HALO -0.80%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -1.91%

HOOK 1.13%

HOTH -2.70%

HOWL -2.14%

HRMY 0.85%

HRTX 1.97%

HSTO 0.00%

HUMA 1.22%

HUMAW -0.01%

IBRX -4.13%

ICCC 0.22%

ICPT 0.21%

ICU 18.15%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.47%

IFRX -2.66%

IGMS -0.11%

IKNA 0.60%

IKT 1.42%

IMAB -0.87%

IMCR -2.60%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -6.96%

IMNM -1.65%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.84%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.63%

INAB 0.59%

INBX 0.00%

INCY -0.87%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 2.66%

INO -1.56%

INSM -0.82%

INTS -2.75%

INVA 0.22%

INZY 0.92%

IOBT -11.02%

IONS 0.05%

IOVA -2.37%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -2.35%

ISEE 0.38%

ITOS -1.57%

ITRM 1.67%

IVA 6.96%

IVVD -3.73%

JAGX 1.04%

JANX -4.27%

JAZZ -0.40%

JNCE 0.00%

JSPR -5.93%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -1.91%

KDNY 0.22%

KMPH -0.34%

KNSA -2.68%

KNTE -0.38%

KOD -7.09%

KPRX 0.96%

KPTI -1.38%

KRBP -10.00%

KRON 1.05%

KROS -1.18%

KRRO -6.34%

KRTX 0.03%

KRYS -0.79%

KTRA 16.15%

KTTA 8.16%

KTTAW 0.92%

KURA -1.81%

KYMR -2.22%

KYTX -3.49%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -0.89%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.65%

LENZ -4.02%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.66%

LPCN -3.16%

LPTX -1.11%

LQDA -0.24%

LRMR -1.92%

LSTA -4.06%

LTRN 0.25%

LUMO -1.32%

LVTX 0.00%

LXEO -4.33%

LXRX -2.06%

LYEL -35.45%

LYRA 3.02%

MACK 0.10%

MBIO -9.40%

MBRX -1.72%

MCRB 1.12%

MDGL -2.35%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -2.81%

MGTA -7.74%

MGTX -2.70%

MGX -2.68%

MIRM -1.42%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.76%

MLYS -5.55%

MNKD -0.95%

MNMD 0.21%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.06%

MORF -4.03%

MREO -4.42%

MRKR 2.68%

MRNA -4.83%

MRNS -4.04%

MRSN -2.62%

MRTX -0.17%

MRUS 0.25%

MRVI -1.97%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.08%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.14%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.87%

NEXI 2.60%

NGM -1.28%

NGNE -1.40%

NKGN 5.88%

NKGNW 8.00%

NKTR -3.72%

NKTX -4.40%

NLSP -2.77%

NLSPW 26.67%

NMRA -0.80%

NMTR -42.97%

NOVN -24.84%

NRBO 12.16%

NRIX -0.62%

NRSN -3.63%

NRSNW 0.00%

NRXP -5.39%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.13%

NTRBW -31.07%

NUVL -1.93%

NVAX -1.79%

NVCT 3.59%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.40%

OABIW -10.06%

OBIO -3.21%

OBSV 0.00%

OCEA 0.00%

OCGN 4.24%

OCS -1.02%

OCUL -1.90%

OCUP 1.97%

ODT -4.27%

OKYO 1.51%

OLMA -5.12%

OMER -0.90%

OMGA 5.41%

ONCO 4.90%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 0.99%

ORGS -4.53%

ORIC -3.56%

ORMP 15.09%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI -0.87%

PASG -1.30%

PBLA -7.50%

PBM -7.49%

PBYI 1.69%

PCSA 0.00%

PCVX -0.42%

PDSB -0.79%

PEPG 0.48%

PGEN -3.59%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.57%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.73%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT 0.28%

PRAX 0.63%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.45%

PRQR -0.01%

PRTA -2.36%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -1.35%

PTCT -0.27%

PTE -0.82%

PTGX -1.47%

PTIXW -49.04%

PULM 2.62%

PXMD 0.00%

PYPD 0.07%

PYXS 2.61%

QLGN -3.72%

QNCX 5.70%

QNRX 0.37%

QSI -11.89%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -2.92%

RARE 1.26%

RCKT -7.95%

REGN -0.66%

RENB -3.41%

REPL -2.50%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.40%

RIGL -3.28%

RLAY -4.39%

RLMD 0.33%

RLYB -0.34%

RNA -0.36%

RNAC -5.65%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.32%

RPTX -2.05%

RUBY 2.70%

RVLP -32.05%

RVMD -1.15%

RVMDW -30.00%

RVNC 1.92%

RVPH -1.19%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.36%

RYTM -6.09%

RYZB 0.02%

RZLT 1.29%

SABS -1.37%

SABSW -11.81%

SAGE 1.47%

SANA -4.15%

SAVA -0.26%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -0.50%

SCPS 0.00%

SEEL -4.09%

SEER -0.44%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.23%

SGMT -1.93%

SGTX -2.56%

SIOX 22.63%

SLDB -5.00%

SLGL 4.00%

SLN -4.21%

SLNO -2.71%

SLRX 5.23%

SLS -2.99%

SMMT -2.62%

SNDX 0.77%

SNGX -3.02%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.30%

SPRC -4.17%

SPRO 0.04%

SRNE -34.00%

SRPT -1.35%

SRRA 0.00%

SRRK -2.48%

SRZN -2.45%

STAB 0.00%

STOK -4.87%

STRO -2.51%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -2.90%

SWTX 0.33%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -8.06%

TARS 0.08%

TBPH 0.71%

TCBP 2.74%

TCDA 0.00%

TCON -2.43%

TCRR 0.00%

TCRT 1.59%

TCRX 2.58%

TECH -0.14%

TENX -1.27%

TERN -6.47%

TFFP -3.05%

TGTX -2.66%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.16%

TNXP -5.98%

TNYA -8.76%

TPST 2.93%

TRDA -3.86%

TRVI 1.15%

TRVN 5.02%

TSHA -23.73%

TSVT -3.19%

TTNP -9.27%

TVTX 0.63%

TYRA -8.19%

UBX -2.12%

UNCY -3.38%

URGN -1.28%

UTHR -0.25%

VACC 11.36%

VALN -2.89%

VAXX 87.50%

VBIV 0.78%

VBLT -8.77%

VCEL -0.09%

VCNX 10.35%

VCYT -1.27%

VERA -2.80%

VERU 0.78%

VERV -2.58%

VIGL 5.11%

VINC 1.62%

VIR 0.76%

VIRI -1.61%

VIRX 2.38%

VKTX -1.13%

VLON -13.04%

VNDA -2.36%

VOR -2.41%

VRCA 0.28%

VRDN -4.15%

VRNA -1.08%

VRPX 0.38%

VRTX 0.33%

VSTM -3.40%

VTGN -0.46%

VTVT -2.97%

VTYX -0.21%

VXRT -2.26%

VYGR -1.66%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.40%

XBIO 0.93%

XBIT 0.21%

XCUR 3.58%

XENE -3.11%

XERS 2.38%

XFOR 3.72%

XLO 1.58%

XLRN 0.00%

XNCR 0.21%

XOMA -3.14%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.63%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.24%

ZNTL -2.86%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-04	Conley Mark William	Sell	25 000	Employee Stock Option (right to buy)
2024-05-03	Skyler Jay S	Buy	0
2024-02-21	Kropotova Alexandra	Buy	140 000	Employee Stock Option (right to buy)
2024-02-21	Sullivan Eddie Joe	Buy	190 000	Employee Stock Option (right to buy)
2024-02-21	Bausch Christoph Lawrence	Buy	140 000	Employee Stock Option (right to buy)

INSIDER POWER
69.75
Last 87 transactions
Buy: 19 533 010 \| Sell: 3 162 658

सहसंबंध (AI algo v.1.1b): Overvalued: -0.28% $2.90 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

SAB Biotherapeutics, Inc. सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
GPRO	0.913
GP	0.908
PETS	0.907
SSTI	0.906
PRTS	0.906
MKTW	0.905
APPS	0.904
AUUD	0.901
TBLT	0.901
AGRX	0.899

10 सबसे अधिक नकारात्मक सहसंबंध
APXI	-0.92
ACGL	-0.905
SWAV	-0.905
TCOM	-0.903
GHRS	-0.902
DXJS	-0.901
HYAC	-0.898
AEAE	-0.897
IBKR	-0.896
COOP	-0.89

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

SAB Biotherapeutics, Inc. वित्तीय

Annual	2023
राजस्व:	$2.24M
सकल लाभ:	$-1.51M (-67.28 %)
EPS:	$-7.64

FY	2023
राजस्व:	$2.24M
सकल लाभ:	$-1.51M (-67.28 %)
EPS:	$-7.64

FY	2022
राजस्व:	$23.90M
सकल लाभ:	$20.61M (86.23 %)
EPS:	$-4.31

FY	2021
राजस्व:	$60.88M
सकल लाभ:	$0.00 (0.00 %)
EPS:	$-0.394

Financial Reports:

No articles found.

SAB Biotherapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases comprising COVID-19 and influenza, immune and autoimmune disorders, such as type 1 diabetes, organ transplantation, and cancer. The company uses its DiversitAb immunotherapy platform to produce fully-human polyclonal antibodies without the need for human donors. Its lead product candidates include SAB-185, a fully-human polyclonal antibody therapeutic candidate that is in Phase III clinical trial for the treatment of COVID-19; and SAB-176, a fully-human polyclonal antibody therapeutic candidate that is in development to treat or prevent severe influenza. The company's pre-clinical product candidates in development for autoimmune diseases include SAB-142 for type 1 diabetes and organ transplant induction/rejection. The company was founded in 2014 and is based in Sioux Falls, South Dakota.